These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab. Ju JH; Kwok SK; Seo SH; Yoon CH; Kim HY; Park SH Clin Rheumatol; 2007 Aug; 26(8):1383-5. PubMed ID: 17039261 [TBL] [Abstract][Full Text] [Related]
11. A case of intestinal Behçet's disease treated with infliximab monotherapy who successfully maintained clinical remission and complete mucosal healing for six years. Maruyama Y; Hisamatsu T; Matsuoka K; Naganuma M; Inoue N; Ogata H; Iwao Y; Kanai T; Hibi T Intern Med; 2012; 51(16):2125-9. PubMed ID: 22892489 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of infliximab in intestinal Behçet's disease: a Korean multicenter retrospective study. Lee JH; Cheon JH; Jeon SW; Ye BD; Yang SK; Kim YH; Lee KM; Im JP; Kim JS; Lee CK; Kim HJ; Kim EY; Kim KO; Jang BI; Kim WH Inflamm Bowel Dis; 2013 Aug; 19(9):1833-8. PubMed ID: 23702810 [TBL] [Abstract][Full Text] [Related]
14. Long-term remission of ocular and extraocular manifestations in Behçet's disease using infliximab. Handa T; Tsunekawa H; Yoneda M; Watanabe D; Mukai T; Yamamura M; Iwaki M; Zako M Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S58-63. PubMed ID: 21968238 [TBL] [Abstract][Full Text] [Related]
15. Updated treatment strategies for intestinal Behçet's disease. Park YE; Cheon JH Korean J Intern Med; 2018 Jan; 33(1):1-19. PubMed ID: 29207867 [TBL] [Abstract][Full Text] [Related]
16. Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature. Almoznino G; Ben-Chetrit E Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S99-102. PubMed ID: 17949561 [TBL] [Abstract][Full Text] [Related]
17. [Two patients with childhood-onset Behcet's disease successfully treated by anti-tumor necrosis factor therapy]. Kaneko U; Kishi T; Kikuchi M; Hara R; Shinoki T; Miyamae T; Imagawa T; Mori M; Yokota S Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(3):157-61. PubMed ID: 20601837 [TBL] [Abstract][Full Text] [Related]
18. Treatment of recalcitrant orogenital ulceration of Behçet's syndrome with infliximab. Robertson LP; Hickling P Rheumatology (Oxford); 2001 Apr; 40(4):473-4. PubMed ID: 11312390 [No Abstract] [Full Text] [Related]
19. Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease. Iwata S; Saito K; Yamaoka K; Tsujimura S; Nawata M; Hanami K; Tanaka Y Mod Rheumatol; 2011 Apr; 21(2):184-91. PubMed ID: 21052764 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease. Sugita S; Kawazoe Y; Imai A; Yamada Y; Horie S; Mochizuki M Arthritis Res Ther; 2012 May; 14(3):R99. PubMed ID: 22546542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]